We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+8.28%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$363M
AUM Growth
+$106M
Cap. Flow
+$82.9M
Cap. Flow %
22.81%
Top 10 Hldgs %
53.43%
Holding
285
New
150
Increased
13
Reduced
21
Closed
82

Sector Composition

Rank Sector Weight
1 Healthcare 20.21%
2 Technology 10.68%
3 Industrials 9.82%
4 Financials 9.54%
5 Consumer Discretionary 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTR
151
Virtus Total Return Fund
ZTR
$340M
$159K 0.04%
+26,136
New +$163K
SABA
152
Saba Capital Income & Opportunities Fund II
SABA
$220M
$151K 0.04%
+18,244
New +$153K
PRTK
153
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$147K 0.04%
+66,402
New +$138K
RIV
154
RiverNorth Opportunities Fund
RIV
$308M
$132K 0.04%
+11,569
New +$129K
UNG icon
155
United States Natural Gas Fund
UNG
$470M
$130K 0.04%
+4,382
New +$119K
ASRT
156
DELISTED
Assertio
ASRT
$128K 0.04%
+1,577
New +$147K
NKTX icon
157
Nkarta
NKTX
$162M
$125K 0.03%
+57,022
New +$251K
VFF icon
158
Village Farms International
VFF
$235M
$120K 0.03%
200,000
SNAL icon
159
Snail Inc
SNAL
$45.5M
$119K 0.03%
15,000
ZFOX
160
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$107K 0.03%
+106,617
New +$118K
GFAI icon
161
Guardforce AI
GFAI
$10.9M
$101K 0.03%
+20,000
New +$201K
UVIX icon
162
2x Long VIX Futures ETF
UVIX
$286M
$98.9K 0.03%
+11
New +$214K
TVRD
163
Tvardi Therapeutics
TVRD
$23.5M
$96.3K 0.03%
+945
New +$130K
TERN
164
DELISTED
Terns Pharmaceuticals
TERN
$93.2K 0.03%
+10,655
New +$124K
AAIC
165
DELISTED
Arlington Asset Investment Corp.
AAIC
$92.6K 0.03%
+20,000
New +$65.2K
CRMD icon
166
CorMedix
CRMD
$617M
$79.3K 0.02%
+20,000
New +$99K
SMMT icon
167
Summit Therapeutics
SMMT
$10.9B
$75.3K 0.02%
30,000
-115,000
-79% -$210K
ABSI icon
168
Absci
ABSI
$1.28B
$73.6K 0.02%
+48,438
New +$77.9K
LOGC
169
DELISTED
ContextLogic
LOGC
$71K 0.02%
+10,793
New +$85.5K
MCRB icon
170
Seres Therapeutics
MCRB
$48M
$67.9K 0.02%
+708
New +$77K
LUMN icon
171
Lumen
LUMN
$6.53B
$62.8K 0.02%
+27,798
New +$61.2K
AMC icon
172
AMC Entertainment Holdings
AMC
$2.03B
$56.3K 0.02%
+1,279
New +$63.2K
FEAM icon
173
5E Advanced Materials
FEAM
$47.7M
$53.3K 0.01%
+707
New +$67.1K
CURO
174
DELISTED
CURO Group Holdings Corp.
CURO
$51.9K 0.01%
+38,457
New +$58.9K
TSP
175
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$45.4K 0.01%
+27,351
New +$44.3K

Similar funds

Alpine Global Management's Q2 2023 Portfolio in Review

As of Q2 2023, Alpine Global Management held 285 positions worth $363M, up 41% from $257M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Alpine Global Management deployed $82.9M of net new capital in Q2 2023, opening 150 new positions and adding to 13 existing holdings. Its largest new stake was Vanguard Mid-Cap ETF: 130,804 shares worth $7.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $3.26M trimmed.

  • Alpine Global Management's largest Q2 2023 buy was Vanguard Mid-Cap ETF: 130,804 shares worth $7.2M.
  • Alpine Global Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2023, an estimated $17M increase.
  • Alpine Global Management's biggest Q2 2023 reduction was Activision Blizzard, cutting an estimated $3.26M.
  • Alpine Global Management fully exited First Republic Bank in Q2 2023, selling an estimated $23.7M.
  • Alpine Global Management's ten largest holdings make up 53% of its $363M portfolio in Q2 2023.
  • Alpine Global Management opened 150 new positions and closed 82 in Q2 2023.
  • Alpine Global Management's portfolio value rose 41% quarter-over-quarter to $363M.

Based on Alpine Global Management's 13F filing for Q2 2023, filed 14 Aug 2023.